Atlas Trials

Study of a Tetravalent Dengue Vaccine in Healthy Adult Subjects Aged 18 to 45 Years in India

Clinical trial NCT01550289 · COMPLETED

Trial details

NCT number
NCT01550289
Sponsor
Sanofi Pasteur, a Sanofi Company
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
DengueDengue FeverDengue Hemorrhagic Fever
Start date
2012-03-01
Primary completion
2013-12-01
Enrollment
189

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.